PROMISE international; a clinical post marketing trial investigating the percutaneous deep vein arterialization (LimFlow) in the treatment of no-option chronic limb ischemia patient

201914 citationsJournal Articlegold Open Access

Authors

NCT03321552 .

Good health and well-being

Published in: CVIR Endovascular

Volume 2, Issue 1, pp. 26-26

Field-Weighted Citation Impact: 1.76